X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (57545) 57545
Newspaper Article (1217) 1217
Newsletter (327) 327
Book Chapter (276) 276
Magazine Article (163) 163
Dissertation (85) 85
Book / eBook (48) 48
Trade Publication Article (44) 44
Web Resource (25) 25
Publication (17) 17
Conference Proceeding (15) 15
Book Review (13) 13
Transcript (11) 11
Paper (5) 5
Journal / eJournal (4) 4
Reference (4) 4
Report (4) 4
Streaming Video (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (46091) 46091
male (28282) 28282
female (27200) 27200
middle aged (23551) 23551
adult (21541) 21541
gastroenterology & hepatology (16328) 16328
aged (12283) 12283
hepatitis c, chronic - drug therapy (12079) 12079
hepatitis c (11795) 11795
antiviral agents - therapeutic use (10881) 10881
hepatitis c virus (9547) 9547
hepatitis (9152) 9152
treatment outcome (7308) 7308
hepatitis c, chronic - complications (7269) 7269
interferon (7147) 7147
hepacivirus - genetics (6749) 6749
risk factors (6727) 6727
liver (6705) 6705
interferon-alpha - therapeutic use (6362) 6362
chronic hepatitis-c (6321) 6321
health aspects (6313) 6313
cirrhosis (6124) 6124
infection (6103) 6103
genotype (6099) 6099
infectious diseases (5464) 5464
hepatitis c, chronic - virology (5456) 5456
drug therapy, combination (5435) 5435
chronic disease (5336) 5336
ribavirin (5323) 5323
therapy (5149) 5149
virus-infection (4922) 4922
virology (4875) 4875
prevalence (4873) 4873
chronic hepatitis c (4848) 4848
adolescent (4804) 4804
ribavirin - therapeutic use (4737) 4737
care and treatment (4526) 4526
fibrosis (4522) 4522
immunology (4516) 4516
analysis (4461) 4461
infections (4399) 4399
retrospective studies (4366) 4366
recombinant proteins (4204) 4204
hepatitis b (4185) 4185
liver cirrhosis (4184) 4184
liver diseases (4084) 4084
liver - pathology (4051) 4051
disease (4005) 4005
hepatocellular-carcinoma (3963) 3963
young adult (3903) 3903
biopsy (3747) 3747
animals (3400) 3400
patients (3389) 3389
hcv (3387) 3387
research (3360) 3360
medicine, general & internal (3340) 3340
hepatocellular carcinoma (3339) 3339
viral load (3317) 3317
antiviral agents - administration & dosage (3263) 3263
antiviral agents - adverse effects (3241) 3241
prognosis (3181) 3181
diagnosis (3111) 3111
gastroenterology and hepatology (3108) 3108
prospective studies (3032) 3032
virus diseases (2941) 2941
antiviral agents (2932) 2932
pharmacology & pharmacy (2923) 2923
transplantation (2901) 2901
chronic infection (2879) 2879
rna, viral - blood (2874) 2874
mortality (2861) 2861
hepatitis c, chronic - pathology (2859) 2859
time factors (2832) 2832
viruses (2735) 2735
follow-up studies (2725) 2725
medicine & public health (2718) 2718
disease progression (2685) 2685
hepatitis b virus (2683) 2683
hepatology (2668) 2668
hepatitis c, chronic - immunology (2665) 2665
aged, 80 and over (2633) 2633
medicine (2603) 2603
polyethylene glycols - therapeutic use (2601) 2601
hepatitis c, chronic - diagnosis (2549) 2549
medical research (2545) 2545
hepacivirus - isolation & purification (2535) 2535
virus (2526) 2526
hepatitis c, chronic - blood (2516) 2516
hepacivirus - drug effects (2506) 2506
hiv (2479) 2479
hepatitis c, chronic - epidemiology (2460) 2460
alanine transaminase - blood (2458) 2458
risk (2455) 2455
surgery (2454) 2454
oncology (2419) 2419
interferon-alpha - administration & dosage (2412) 2412
liver cirrhosis - pathology (2405) 2405
severity of illness index (2397) 2397
epidemiology (2372) 2372
interferon-alpha - adverse effects (2369) 2369
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (16) 16
Online Resources - Online (14) 14
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Baycrest Hospital - Wellness Library (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Library use only (1) 1
Knox College (Caven) - Stacks (1) 1
OISE - Reference (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
University College (Laidlaw) - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (54304) 54304
French (1275) 1275
Japanese (857) 857
Spanish (847) 847
German (628) 628
Russian (505) 505
Chinese (479) 479
Korean (400) 400
Polish (253) 253
Italian (184) 184
Portuguese (156) 156
Hungarian (110) 110
Turkish (80) 80
Czech (72) 72
Croatian (45) 45
Serbian (31) 31
Danish (22) 22
Romanian (22) 22
Swedish (17) 17
Dutch (16) 16
Norwegian (14) 14
Slovak (13) 13
Arabic (9) 9
Hebrew (9) 9
Ukrainian (8) 8
Persian (6) 6
Bosnian (4) 4
Finnish (4) 4
Bulgarian (3) 3
Belarusian (2) 2
Albanian (1) 1
Azerbaijani (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Internal Medicine, ISSN 0003-4819, 03/2014, Volume 160, Issue 6, pp. 369 - 379
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 01/2011, Volume 121, Issue 1, pp. 308 - 317
Chronic infection with hepatitis C virus (HCV) is a major public health problem, with nearly 170 million infected individuals worldwide Current treatment for chronic infection is a combination of pegylated. IFN-alpha(2) and ribavirin (RBV... 
MEDICINE, RESEARCH & EXPERIMENTAL | LIVER INFLAMMATION | GAMMA-INDUCIBLE PROTEIN-10 | VIRUS-INFECTION | DIPEPTIDYL-PEPTIDASE-IV | ANTIVIRAL THERAPY | INSULIN-RESISTANCE | IMMUNE-RESPONSES | CHRONIC HEPATITIS-C | LEVELS CORRELATE | PEGINTERFERON PLUS RIBAVIRIN | Chemokine CXCL10 - blood | Prognosis | Antiviral Agents - therapeutic use | Receptors, CXCR3 - blood | Humans | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Chemokine CXCL10 - antagonists & inhibitors | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Hepatitis C, Chronic - therapy | Recombinant Proteins | Hepatitis C, Chronic - blood | Polyethylene Glycols - therapeutic use | T-Lymphocytes - virology | Treatment Failure | Hepatitis C, Chronic - immunology | Peptide Fragments - blood | Protein Array Analysis | T-Lymphocytes - immunology | Proteases | Physiological aspects | Research | Diagnosis | Hepatitis C | Drug therapy | Chemokines | Hepatitis C, Chronic/therapy | T-Lymphocytes/immunology | Polyethylene Glycols/therapeutic use | Dipeptidyl Peptidase 4/blood | Receptors, CXCR3/blood | Chemokine CXCL10/blood | T-Lymphocytes/virology | Hepatitis C, Chronic/blood | Interferon-alpha/therapeutic use | Chemokine CXCL10/antagonists & inhibitors | Life Sciences | Immunology | Antiviral Agents/therapeutic use | Hepatitis C, Chronic/immunology | Peptide Fragments/blood | Ribavirin/therapeutic use | Hepatitis C, Chronic/virology
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2014, Volume 61, Issue 1, pp. S58 - S68
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 11/2016, Volume 165, Issue 9, pp. 625 - 634
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 364, Issue 25, pp. 2429 - 2438
Journal Article
Hepatology, ISSN 0270-9139, 08/2017, Volume 66, Issue 2, pp. 344 - 356
... (HIV)/hepatitis C virus (HCV)–coinfected patients treated with interferon (IFN) and ribavirin (RBV), between 2000 and 2008... 
SUSTAINED VIROLOGICAL RESPONSE | HEART-DISEASE | HIV-INFECTION | ENDOTHELIAL DYSFUNCTION | INCREASED RISK | ANTIVIRAL TREATMENT | CHRONIC KIDNEY-DISEASE | CHRONIC HCV INFECTION | GASTROENTEROLOGY & HEPATOLOGY | CORONARY-ARTERY-DISEASE | BONE TURNOVER | Follow-Up Studies | Coinfection - drug therapy | Humans | Middle Aged | Male | Coinfection - physiopathology | HIV - drug effects | Incidence | Time Factors | Adult | Female | Retrospective Studies | Hepatitis C, Chronic - epidemiology | Drug Therapy, Combination | Databases, Factual | Hepacivirus - drug effects | Hepacivirus - isolation & purification | Risk Assessment | Comorbidity | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Treatment Outcome | HIV - isolation & purification | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Acquired Immunodeficiency Syndrome - drug therapy | Regression Analysis | Spain - epidemiology | Survival Analysis | Acquired Immunodeficiency Syndrome - epidemiology | Acquired Immunodeficiency Syndrome - diagnosis | Cohort Studies | Kidneys | Diabetes mellitus | Liver | Lymphocytes T | Regression analysis | Ribonucleic acid--RNA | Ribavirin | Immunosuppressive agents | Antiretroviral therapy | CD4 antigen | Hepatitis | Bone cancer | Disease transmission | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Fibrosis | Renal failure | Death | Interferon | Diabetes | Hepatitis C | Kidney transplantation | Cancer | Original
Journal Article